An 18-month-old child with upper respiratory symptoms, high fever, and a dry, hacking cough has a negative rapid influenza test and a viral culture pending. What should the clinician do?

An 18-month-old child with upper respiratory symptoms, high fever, and a dry, hacking cough has a negative rapid influenza test and a viral culture pending. What should the clinician do?

• A. Consider therapy with rimantadine.
• B. Hospitalize for supportive treatment.
• C. Prescribe oseltamivir and follow closely
• D. Wait for cultures to determine treatment.

Answer: (C)

Start antiviral therapy now. In young children, rapid influenza tests can miss many true influenza cases, so a negative result does not rule out illness when clinical suspicion is high. Beginning oseltamivir within the early window of illness reduces duration and lowers the risk of complications, and it is effective against both influenza A and B. Waiting for culture results would delay treatment for several days, potentially reducing benefit. Rimantadine is not preferred due to resistance and limited effectiveness in circulating strains, and hospitalization or waiting for culture is not indicated unless the child shows signs of severe illness or dehydration. Provide supportive care and closely monitor the child, but start oseltamivir now.

Start antiviral therapy now. In young children, rapid influenza tests can miss many true influenza cases, so a negative result does not rule out illness when clinical suspicion is high. Beginning oseltamivir within the early window of illness reduces duration and lowers the risk of complications, and it is effective against both influenza A and B. Waiting for culture results would delay treatment for several days, potentially reducing benefit. Rimantadine is not preferred due to resistance and limited effectiveness in circulating strains, and hospitalization or waiting for culture is not indicated unless the child shows signs of severe illness or dehydration. Provide supportive care and closely monitor the child, but start oseltamivir now.